Maffi, Paola <br/><br/>
Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.  [electronic resource] 

 -  Diabetes care  May 2007 
 - 1150-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1935-5548 
<br/><br/><label>Standard No.: </label>10.2337/dc06-1794  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Creatinine--blood<br/>Daclizumab<br/>Diabetes Mellitus, Type 1--physiopathology<br/>Diabetic Nephropathies--chemically induced<br/>Disease Progression<br/>Follow-Up Studies<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Immunoglobulin G--adverse effects<br/>Immunosuppressive Agents--adverse effects<br/>Insulin--therapeutic use<br/>Islets of Langerhans Transplantation--physiology<br/>Kidney Function Tests<br/>Retrospective Studies<br/>Sirolimus--adverse effects<br/>Tacrolimus--adverse effects